Real-World Outcomes of Radium-223 Therapy in Metastatic Castration-Resistant Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide Continuation. [PDF]
Abe K +14 more
europepmc +1 more source
Abstract Beyond physical challenges, cancer can cause psychological and cognitive challenges for patients, caregivers, and family members. Digital health interventions show promise in addressing these issues. However, evidence on their applicability in daily cancer care is limited. The objective of this systematic review is to evaluate the internal and
Melissa Heifez +16 more
wiley +1 more source
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801). [PDF]
McKay RR +25 more
europepmc +1 more source
Function drives 1‐year decision regret in radical prostatectomy: a multicentre prospective study
Objectives To identify contemporary drivers of postoperative decision regret 1 year after radical prostatectomy (RP). Patients and Methods In this prospective, multicentre study, patients undergoing robot‐assisted RP (RARP) or retropubic open RP (ORP) for localised prostate cancer at seven centres in Germany and Austria (2022–2024) completed ...
Christopher Hirtsiefer +14 more
wiley +1 more source
ABSTRACT Aim Although finerenone has shown efficacy in randomized trials, evidence from routine clinical practice remains limited. We aimed to assess the real‐world effectiveness and safety of finerenone in people with type 2 diabetes (PWT2D) and chronic kidney disease (CKD), with a particular focus on residual cardiorenal risk as reflected by changes ...
Oscar Moreno‐Pérez +13 more
wiley +1 more source
Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer <i>in vitro</i> models. [PDF]
Dunne VL +6 more
europepmc +1 more source
Prostate cancer – Therapy with radium-223 [PDF]
Ana Emília, Brito +4 more
openaire +2 more sources
Setting of an import tolerance maximum residue limit for dimethomorph in hops
Abstract In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant BASF Agro B.V. Arnhem (NL) Freienbach Branch submitted a request to the competent national authority in the Netherlands to set an import tolerance for the active substance dimethomorph in hops imported from the United States. The data submitted in support of the request
EFSA (European Food Safety Authority) +10 more
wiley +1 more source
Real-world effectiveness and safety of radium-223 therapy in castration-resistant prostate cancer with bone metastases. [PDF]
Wang HK +11 more
europepmc +1 more source
Radium-223 and bone metastatic disease: still more to learn. [PDF]
Sartor O.
europepmc +1 more source

